drugset / Trial / NCT00319670
A Pilot Study of a New MiraLax® Dose Formulation For Use in Constipated Children
Non-randomizedSingle-groupOpen-labelTreatment
Summary
To evaluate patient acceptance of a new MiraLax dose formulation in children currently treated with polyethylene glycol 3350 powder for treatment of constipation.
Timeline
- Start
- 2006-03
- Primary completion
- 2006-05
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | polyethylene glycol | Other / unclassified | — | — |